Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations
出版年份 2019 全文链接
标题
Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations
作者
关键词
-
出版物
Cancers
Volume 11, Issue 2, Pages 266
出版商
MDPI AG
发表日期
2019-02-25
DOI
10.3390/cancers11020266
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumor-infiltrating BRAFV600E-specific CD4+ T cells correlated with complete clinical response in melanoma
- (2018) Joshua R. Veatch et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Evolutionary Pressure against MHC Class II Binding Cancer Mutations
- (2018) Rachel Marty et al. CELL
- Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses
- (2018) Jasmin Quandt et al. OncoImmunology
- Trial watch: peptide-based vaccines in anticancer therapy
- (2018) Lucillia Bezu et al. OncoImmunology
- Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
- (2018) Brendan Bulik-Sullivan et al. NATURE BIOTECHNOLOGY
- Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
- (2017) Zinal S. Chheda et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma
- (2017) Julie S. Nielsen et al. OncoImmunology
- A novel, rapid and efficient method of cloning functional antigen-specific T-cell receptors from single human and mouse T-cells
- (2016) Hiroshi Hamana et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
- (2016) E. Stronen et al. SCIENCE
- T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules
- (2015) Jamie Rossjohn et al. Annual Review of Immunology
- Targeting cancer-specific mutations by T cell receptor gene therapy
- (2015) Thomas Blankenstein et al. CURRENT OPINION IN IMMUNOLOGY
- Gene of the month:PIK3CA
- (2015) K Lai et al. JOURNAL OF CLINICAL PATHOLOGY
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study
- (2015) N. Ikeda et al. TISSUE ANTIGENS
- C-KIT Signaling in Cancer Treatment
- (2014) Karmen Stankov et al. CURRENT PHARMACEUTICAL DESIGN
- Development and Function of Dendritic Cell Subsets
- (2014) Alexander Mildner et al. IMMUNITY
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More